aristolochic acid i has been researched along with curcumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
| Gao, H; Jiang, X; Liu, Z; Ma, J; Shi, B; Wang, Y; Xu, Q; Yu, W | 1 |
2 other study(ies) available for aristolochic acid i and curcumin
| Article | Year |
|---|---|
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |
Curcumin alleviates aristolochic acid nephropathy based on SIRT1/Nrf2/HO-1 signaling pathway.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Aristolochic Acids; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Curcumin; Kelch-Like ECH-Associated Protein 1; Kidney Diseases; Lipocalin-2; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sirtuin 1; Superoxide Dismutase | 2022 |